Glycovax-NRC-prod-CRM197-NR-EN-03-06-25

By Claude Dagenais | March 6, 2025

Glycovax Pharma pursues commercial production of the CRM197 carrier protein
for conjugate vaccines under exclusive license
from the National Research Council Canada (NRC)